We found ox-LDL-induced the phosphorylation of ERK1/2 in VSMCs, AD inhibited the ERK1/2 pathway activation, and blocking ERK1/2 pathways dramatically suppressed miR-17∼92a cluster expression. The gene discussed is MAPK3; the disease is Alzheimer disease.